U.S. Food and Drug Administration staff reviewers on Sunday said Pfizer-BioNTech’s (PFE.N), COVID-19 vaccines were effective and safe for use in children aged 6 months to 4 years.
The FDA reviewers said in briefing documents published on Sunday evening that their evaluation did not reveal any new safety concerns related to the use of the vaccine in young children.
“Available data support the effectiveness of the Pfizer-BioNTech COVID-19 Vaccine 3-dose primary series in preventing COVID-19 in the age group of 6 months through 4 years,” FDA staff said in the review.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer COVID shot safe and effective for children under 5, review by FDA scientists findsThe FDA's independent experts are meeting this week to consider emergency use authorization of the vaccine for young children.
Read more »
Covid: Dozens of Covid cases linked to Beijing barMass testing is taking place after more than 160 cases are linked to a bar in the capital.
Read more »
Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review SaysThree doses of the Covid-19 vaccine from Pfizer and BioNTech were effective at preventing symptomatic disease in children ages 6 months through 4 years in studies, according to U.S. health regulators.
Read more »
US: Pfizer COVID-19 vaccine appears effective for kids under 5A review by federal health officials says that Pfizer's COVID-19 vaccine appears safe and effective for children under 5.
Read more »
Pfizer COVID-19 vaccine appears effective for kids under 5: officialsThe Food and Drug Administration posted its analysis ahead of a Wednesday meeting where outside experts will vote on whether the shots are ready for the nation’s 18 million babies, toddlers and preschoolers.
Read more »
US: Pfizer COVID-19 shot appears effective for kids under 5WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to begin vaccinating the youngest American children .
Read more »